Encapsulation of Cryptococcus neoformans with Glucuronoxylomannan Inhibits the Antigen-Presenting Capacity of Monocytes
This report examines the effect of the major capsular polysaccharide of Cryptococcus neoformans, glucuronoxylomannan (GXM), on the antigen-presenting capability of human monocytes treated with acapsular cells of C. neoformans. We found that pretreatment of acapsular cryptococci with GXM downregulate...
Guardat en:
| Publicat a: | Infect Immun |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1998
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC107954/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9453624/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.66.2.664-669.1998 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|